Status: current, Primitive. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2115241000168115 | Tecentriq (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2115251000168118 | Tecentriq | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tecentriq | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has TP | True | Tecentriq | Inferred relationship | Some | |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | has TP | True | Tecentriq | Inferred relationship | Some | |
| Tecentriq 840 mg/14 mL injection, 14 mL vial | Is a | True | Tecentriq | Inferred relationship | Some | |
| Tecentriq 1.2 g/20 mL injection, 20 mL vial | Is a | True | Tecentriq | Inferred relationship | Some | |
| Tecentriq 1.2 g/20 mL injection, 20 mL vial | has TP | True | Tecentriq | Inferred relationship | Some | |
| Tecentriq 1.2 g/20 mL injection, 20 mL vial | has TP | True | Tecentriq | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR